FAMOTIDINE PRESERVATIVE FREE Drug Patent Profile
When do Famotidine Preservative Free patents expire, and what generic alternatives are available?
Famotidine Preservative Free is a drug marketed by Apothecon, Epic Pharma Llc, Fresenius Kabi Usa, Hikma, Hospira, Mylan Labs Ltd, Sagent, Abbvie, and Baxter Hlthcare. and is included in twelve NDAs.
The generic ingredient in FAMOTIDINE PRESERVATIVE FREE is famotidine. There is one drug master file entry for this compound. One hundred and forty-nine suppliers are listed for this compound. Additional details are available on the famotidine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Famotidine Preservative Free
A generic version of FAMOTIDINE PRESERVATIVE FREE was approved as famotidine by FRESENIUS KABI USA on April 16th, 2001.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FAMOTIDINE PRESERVATIVE FREE?
- What are the global sales for FAMOTIDINE PRESERVATIVE FREE?
- What is Average Wholesale Price for FAMOTIDINE PRESERVATIVE FREE?
Summary for FAMOTIDINE PRESERVATIVE FREE
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 12 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 64 |
| DailyMed Link: | FAMOTIDINE PRESERVATIVE FREE at DailyMed |
Pharmacology for FAMOTIDINE PRESERVATIVE FREE
| Drug Class | Histamine-2 Receptor Antagonist |
| Mechanism of Action | Histamine H2 Receptor Antagonists |

